Abstract
Hepatocellular carcinoma (HCC) is the commonest primary cancer of the liver. Geographical distribution of HCC varies throughout the world with an incidence rate ranging from 2.1 in Central America to 35.5 in Eastern Asia. The burden of HCC has been increasing in Egypt with a doubling in the incidence rate in the past 10 years. This may be attributed to high prevalence of HCV in Egypt. Egypt has a high incidence of HCC about 21% in cirrhotic Egyptian patients. HCV and HBV infections, diabetes and smoking are the main determinants of HCC development in Egypt. Occult HBV infection may influence the outcome of HCV infection leading to development of HCC. An active surveillance and secondary prevention programs for patients with chronic hepatitis are the most important steps to reduce the risk of HCC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
